Nav1.8 inhibitors (Iongen Therapeutics)

Nav1.8抑制剂 (阳光安津)

Report date: 2025/01/17 15:10:42
NME

Base Information

Drug NameNav1.8 inhibitors (Iongen Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit inhibitors
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesIongen Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIongen Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A